^
CSF3R T618I
Chronic Neutrophilic Leukemia
ruxolitinib
Sensitive: C3 – Early Trials
CSF3R S783
Chronic Neutrophilic Leukemia
dasatinib
Sensitive: D – Preclinical
CSF3R T618I
Chronic Neutrophilic Leukemia
dasatinib
Resistant: D – Preclinical